AK-0802

N/A

Report date: 2022/02/18 14:31:07
NME

Base Information

Drug NameAK-0802
Drug Alias NameAK-0802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIleal bile acid transporter inhibitors
TargetsIleal bile acid transporter
Therapy Area/IndicationsProgressive familial intrahepatic cholestasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Ark Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProgressive familial intrahepatic cholestasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A